Younossi ZM - Search Results

1

Depression, anemia and health-related quality of life in chronic hepatitis C.

Dan AA, Martin LM, Crone C, Ong JP, Farmer DW, Wise T, Robbins SC, Younossi ZM. Dan AA, et al. Among authors: younossi zm. J Hepatol. 2006 Mar;44(3):491-8. doi: 10.1016/j.jhep.2005.11.046. Epub 2005 Dec 27. J Hepatol. 2006. PMID: 16427157

2

The impact of liver disease on health-related quality of life: a review of the literature.

Martin LM, Sheridan MJ, Younossi ZM. Martin LM, et al. Among authors: younossi zm. Curr Gastroenterol Rep. 2002 Feb;4(1):79-83. doi: 10.1007/s11894-002-0041-z. Curr Gastroenterol Rep. 2002. PMID: 11825545 Review.

3

Nonalcoholic fatty liver disease: an agenda for clinical research.

Younossi ZM, Diehl AM, Ong JP. Younossi ZM, et al. Hepatology. 2002 Apr;35(4):746-52. doi: 10.1053/jhep.2002.32483. Hepatology. 2002. PMID: 11915019 Review. No abstract available.

4

Advances in treatment of chronic hepatitis C: 'pegylated' interferons.

Sharieff KA, Duncan D, Younossi Z. Sharieff KA, et al. Cleve Clin J Med. 2002 Feb;69(2):155-9. doi: 10.3949/ccjm.69.2.155. Cleve Clin J Med. 2002. PMID: 11990646 Free article. Review.

5

Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?

Ong JP, Younossi ZM. Ong JP, et al. Among authors: younossi zm. Gastroenterology. 2002 Jul;123(1):375-8. doi: 10.1053/gast.2002.34453. Gastroenterology. 2002. PMID: 12105866 Review. No abstract available.

6

Non-alcoholic fatty liver disease: an overview.

Mulhall BP, Ong JP, Younossi ZM. Mulhall BP, et al. Among authors: younossi zm. J Gastroenterol Hepatol. 2002 Nov;17(11):1136-43. doi: 10.1046/j.1440-1746.2002.02881.x. J Gastroenterol Hepatol. 2002. PMID: 12453271 Review.

7

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, Younossi Z, Albrecht J. Poynard T, et al. Hepatology. 2003 Jul;38(1):75-85. doi: 10.1053/jhep.2003.50267. Hepatology. 2003. PMID: 12829989 Clinical Trial.

8

Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history?

Ong JP, Younossi ZM. Ong JP, et al. Among authors: younossi zm. Am J Gastroenterol. 2003 Sep;98(9):1915-7. doi: 10.1111/j.1572-0241.2003.07667.x. Am J Gastroenterol. 2003. PMID: 14499766 No abstract available.

9

Treatment options for nonresponders and relapsers to initial therapy for hepatitis C.

Duncan M, Younossi Z. Duncan M, et al. Cleve Clin J Med. 2003 Sep;70 Suppl 4:S21-6. doi: 10.3949/ccjm.70.suppl_4.s21. Cleve Clin J Med. 2003. PMID: 14558642 Free article. Review.

10

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

Younossi ZM, McCullough AJ, Ong JP, Barnes DS, Post A, Tavill A, Bringman D, Martin LM, Assmann J, Gramlich T, Mullen KD, O'Shea R, Carey WD, Ferguson R. Younossi ZM, et al. J Clin Gastroenterol. 2004 Sep;38(8):705-9. doi: 10.1097/01.mcg.0000135372.10846.2a. J Clin Gastroenterol. 2004. PMID: 15319656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters